Repare Therapeutics Inc is a biotechnology company focused on developing innovative cancer therapies through its proprietary gene-targeted platform

The company specializes in identifying and addressing specific genetic vulnerabilities in tumors, aiming to create precision medicines that can effectively treat a range of cancers while minimizing side effects. By leveraging advanced genomic insights, Repare Therapeutics strives to enhance patient outcomes and contribute to the evolving landscape of oncology, emphasizing research and development of therapies that target the underlying genetic alterations driving cancer progression.